Global Diagnostics Health Services Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-12-2024
- Paid Up Capital ₹ 0.10 M
as on 21-12-2024
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2019
- Revenue %
(FY 2019)
- Profit 24.24%
(FY 2019)
- Net Worth -70.77%
(FY 2019)
- Total Assets %
(FY 2019)
About Global Diagnostics Health Services
The Corporate was formerly known as Arch Corporate Consultants Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ajay Gupta and Rina Bansal serve as directors at the Company.
- CIN/LLPIN
U74900DL2008PTC175195
- Company No.
175195
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2008
- Date of AGM
17 Jul 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Global Diagnostics Health Services?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ajay Gupta | Managing Director | 12-Mar-2008 | Current |
Board Members(1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Rina Bansal | Director | 24-Jul-2010 | Current |
Financial Performance of Global Diagnostics Health Services.
Global Diagnostics Health Services Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 24.24% increase in profit. The company's net worth observed a substantial decline by a decrease of 70.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
What is the Ownership and Shareholding Structure of Global Diagnostics Health Services?
In 2017, Global Diagnostics Health Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Arch Health Care Private LimitedActive 16 years 10 months
Ajay Gupta and Rina Bansal are mutual person
- Archtech Buildwell Private LimitedActive 15 years 4 months
Ajay Gupta and Rina Bansal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Global Diagnostics Health Services?
Unlock and access historical data on people associated with Global Diagnostics Health Services, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Global Diagnostics Health Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Global Diagnostics Health Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.